Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione mat2a

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma PF-9366 | Mat2A Inhibitor |

PF 9366 Mat2A Inhibitor MedChemExpress Design and Structural Optimization of Methionine Adenosyltransferase 2A ( MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability Journal of Medicinal Chemistry glutathione mat2a Human and MAT2B genetic polymorphisms observed during Upregulation of MAT2A led to Reciprocal links between methionine metabolism, DNA repair and therapy resistance in glioblastoma bioRxiv Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors Journal of Medicinal Chemistry

SKU: 15400697091 · From vanierexcavation.com

4.3
USD27.43 USD64.43

Pay in 4 interest-free payments of $6.86 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

277 Among them, lamin A/C represents an epigenetic regulator of ageing partially due to its direct interaction with chromatin in a specific DNA sequence termed the lamin A-associated domains (LADs)

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma PF-9366 | Mat2A Inhibitor |

Expression of delta(1)-pyrroline-5-carboxylate synthetase gene during drought in rice ( Oryza sativa L.)

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma PF-9366 | Mat2A Inhibitor |

15% were in the CDDP-only group, although this difference was not statistically significant (P = 0.13)

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma PF-9366 | Mat2A Inhibitor |

Nature Methods

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma PF-9366 | Mat2A Inhibitor |

The transferrin receptor: a potential molecular imaging marker for human cancer

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma PF-9366 | Mat2A Inhibitor |
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products